Home / Cefepime and Beta-Lactamase Inhibitor / Italy
IT ATC J01DE51 · updated 2 Nov 2026
Cefepime and Beta-Lactamase Inhibitor shortage in Italy
Is there a Cefepime and Beta-Lactamase Inhibitor shortage in Italy?
Yes. As of 2 Nov 2026, 1 Cefepime and Beta-Lactamase Inhibitor product is reported short in Italy, the first since 7 Aug 2026. The company estimate for the return is 31 Jan 2027. Main reason: distribution or logistics.
Not reported short in any other country we track. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | EXBLIFEP discontinuation | ADVANZ PHARMA LIMITED | 7 Aug 2026 | 31 Jan 2027 | Distribution or logistics Ridotta disponibilità: distribuzione contingentata |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.